Reports

The objective of this desk review is to evaluate Village of Atmautluak's documentation supporting the uses of its Coronavirus Relief Fund proceeds as reported in GrantSolutions and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period of March 1, 2020 through December 31, 2021.

The objective of this desk review is to evaluate Village of Wainwright's documentation supporting the uses of its Coronavirus Relief Fund proceeds as reported in GrantSolutions and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period of March 1, 2020 through December 31, 2021.

The objective of this desk review is to review Native Village of Kwigillingok's documentation supporting the uses of its Coronavirus Relief Fund (CRF) proceeds and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period of March 1, 2020 through December 31, 2022.

The objective of this desk review is to evaluate Native Village of Kiana’s documentation supporting the uses of its Coronavirus Relief Fund (CRF) proceeds and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period of March 1, 2020 through December 31, 2022.

The objective of this desk review is to review Pedro Bay Village’s documentation supporting the uses of its Coronavirus Relief Fund proceeds and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period of March 1, 2020 through December 31, 2021.

The objective of this desk review is to review New Stuyahok Village’s documentation supporting the uses of its Coronavirus Relief Fund (CRF) proceeds and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period of March 1, 2020 through December 31, 2022.

The objective of this desk review is to evaluate Puerto Rico's documentation supporting the uses of its Coronavirus Relief Fund (CRF) proceeds as reported in GrantSolutions and to assess risk of unallowable use of funds. The scope of our review will include obligation and expenditure data for the period of March 1, 2020 through June 30, 2021.

The Office of the Special Inspector General for Pandemic Recovery is evaluating funds that were allocated to the Federal Reserve System’s Main Street Lending Program (MSLP), which had 319 lenders and 1,830 borrowers participating in loans totaling more than $17 billion. The objectives of the audit are to 1) assess the process used by banks to issue loans under the MSLP program; 2) evaluate the process used by the Federal Reserve’s Special Purpose Vehicle to purchase the loans;  3) determine vulnerabilities based on a risk-based analysis; and 4) identify specific areas that warrant further audit work.
 

The Health Resources and Services Administration (HRSA) awarded nearly $2 billion in supplemental grant funding to 1,387 health centers nationwide in fiscal year (FY) 2020 to respond to the COVID-19 public health emergency. The funding was intended to support the health centers' activities related to the detection, prevention, diagnosis, and treatment of COVID-19, including maintaining or increasing health center capacity and staffing levels during the pandemic, and expanding COVID-19 testing. The performance period for each of these one-time supplemental grant awards, which HRSA began awarding in March 2020, is 12 months. Health centers were permitted to charge to their awards pre-award costs in order to support expenses related to the COVID-19 public health emergency dating back to January 20, 2020. We will determine whether health centers used their HRSA COVID-19 supplemental grant funding in accordance with Federal requirements and grant terms.

Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020.